Pregled po CROSBI profilu: Silvija Canecki Varžić (CROSBI Profil: 33288, MBZ: 353594)
Pronađeno 36 radova
-
26.(DEVOTE Study Group) Marso, SP; McGuire, DK; Zinman, B; Poulter, NR; Emerson, SS; Pieber, TR; Pratley, RE; Haahr, PM; Lange, M; Brown-Frandsen, K et al.Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. // The New England journal of medicine, 377 (2017), 8; 723-732 doi:10.1056/NEJMoa1615692 (međunarodna recenzija, članak, znanstveni)
-
27.(EMPA-REG OUTCOME Investigators) Wanner, Christoph; ...Tušek, Srećko; Mirošević, Gorana, Goldoni, Vesna; Jurišić-Eržen, Dubravka; Balaško, Annemarie; Balić, Stjepan; Drvodelić- Šunić, Ema; Canecki Varžić, Silvija; ...Zinman, BernardEmpagliflozin and Progression of Kidney Disease in Type 2 Diabetes // New England Journal of Medicine, 375 (2016), 4; 323-334 doi:10.1056/nejmoa1515920 (međunarodna recenzija, članak, znanstveni)
-
28.Rahelić, Dario; Altabas, Velimir; Bakula, Miro; Balić, Stjepan; Balint, Ines; Bergman Marković, Biserka; Bičanić, Nenad; Bjelinski, Igor; Božikov, Velimir; Canecki Varžić, Silvija et al.Hrvatske smjernice za farmakološko liječenje šećerne bolesti tipa 2 // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 138 (2016), 1-2; 1-21 (podatak o recenziji nije dostupan, članak, stručni)
-
29.Canecki-Varžić, Silvija; Prpić-Križevac, Ivana; Bilić-Čurčić, InesPlasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus // BMC Endocrine Disorders, 16 (2016), 14-1 doi:10.1186/s12902-016-0094-x (međunarodna recenzija, članak, znanstveni)
-
30.(EMPA-REG OUTCOME Investigators) Zinman, Bernard; ...Tušek, Srećko; Mirošević, Gorana, Goldoni, Vesna; Jurišić-Eržen, Dubravka; Balaško, Annemarie; Balić, Stjepan; Drvodelić- Šunić, Ema; Canecki Varžić, Silvija; ... Inzucchi, Silvio E.Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes // New England Journal of Medicine, 373 (2015), 22; 2117-2128 doi:10.1056/nejmoa1504720 (međunarodna recenzija, članak, znanstveni)
-
31.Canecki-Varžić, Silvija; Prpić-Križevac, Ivana; Bilić-Čurčić, InesRelationship among plasminogen activator inhibitor-1, bone mineral density, metabolic and bone turnover markers in postmenopausal women with type 2 diabetes mellitus // 17th European Congress of Endocrinology
Dublin, Irska, 2015. (poster, sažetak, ostalo) -
32.Canecki-Varzic, Silvija; Prpić-Križevac, Ivana; Bilić-Čurčić, InesConcentrations of the vitamin D metabolite 1, 25(OH)2D and its relationship to inflammatory and metabolic parameters in diabetes type 2 // 17th European Congress of Endocrinology
Dublin, Irska, 2015. (poster, sažetak, ostalo) -
33.Canecki-Varžić, Silvija; Prpić-Križevac, Ivana; Jandrić Balen, Marica; Marjanac, Igor; Mihaljević SilvioType 2 diabetes patient profile at initiation of insulin therapy: croatian single-center cross sectional study. // Diabetologia Croatica, 44 (2015), 2; 41-47 (međunarodna recenzija, članak, znanstveni)
-
34.Makarović, Sandra; Bilić-Čurčić, Ines; Canecki- Varžić, Silvija; Prpić-Križevac, Ivana; Makarović, Zorin; Lešnjaković, SilvijaOsteoprotegerin levels predict calcification and atherosclerosis in hypertension and diabetes type 2 // The 5th Croatian Diabetes Congress 2013
Pula, Hrvatska, 2013. (poster, sažetak, ostalo) -
35.Canecki-Varžić, Silvija; Bilić-Čurčić, InesBone mineral density in relation to metabolic syndrome in postmenopausal women with diabetes type 2 // 15th International & 14th European Congress of Endocrinology
Firenca, Italija, 2012. (poster, sažetak, ostalo) -
36.Canecki-Varžić, Silvija; Bilić-Čurčić, InesOsteocalcin is associated to metabolic syndrome independent of glycaemic control in postmenopausal women with diabetes type 2 // 5th Croatian Scientific Conference on Endocrinology and Metabolism
Pula, Hrvatska, 2011. (poster, sažetak, ostalo)
